CTOs on the Move

Glaukos

www.glaukos.com

 
Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures to transform the treatment of glaucoma, one of the world`s leading causes of blindness. Glaukos has pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to revolutionize the traditional glaucoma treatment and management paradigm. The company launched the iStent Trabecular Micro-Bypass Stent, its first MIGS device, in the United States in 2012. Glaukos is leveraging its platform technology to build a comprehensive and proprietary portfolio of injectable micro-scale therapies designed to address the complete range of glaucoma disease states and progression. Glaukos believes the ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.glaukos.com
  • 229 Avenida Fabricante
    San Clemente, CA USA 92672
  • Phone: 949.481.0510

Executives

Name Title Contact Details

Similar Companies

JEOL

JEOL USA, Inc. is a wholly owned subsidiary of JEOL, Ltd. of Akishima, Japan.JEOL USA, Inc. was incorporated in the United States in 1962, and moved to present corporate offices at 11 Dearborn Road in Peabody, Massachusetts, in August 1979. The primary

MedVenture Technology Corporation

MedVenture Technology dedicates resources to building a strong community. Employees passionate about a charitable organization are encouraged to share their enthusiasm at work. Volunteers are recruited, donations are accepted, and families all around us

North American Medical Management

North American Medical Management is a Ontario, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Benvenue Medical

Founded in 2004, Benvenue Medical, Inc. provides next generation minimally invasive systems for spine repair that combine expandable implants with novel delivery instruments to provide enduring functional benefits for patients. The company is privately held and funded by InterWest Partners, Versant Ventures, DeNovo Ventures, Domain Associates and Technology Partners. Its first products are designed for the treatment of vertebral compression fractures and degenerative disc disease, which have combined revenues of $9 billion globally.

VentureMed Group

VentureMed Group, Inc. is a commercial-stage medical device company that develops and markets cost-effective interventional devices to improve the treatment of peripheral artery disease.